I'll create a comprehensive venue mapping for your MIL transfer paper. Since I don't have your current draft, I'll provide a **complete venue comparison matrix** and **adaptable submission plan** you can customize.

---

## üéØ VENUE COMPARISON MATRIX: MIL Transfer Learning Paper

### Tier 1: Premier ML Conferences

| Venue | Deadline | Pages | Anonymization | Code/Data | Artifacts | Best Fit Score |
|-------|----------|-------|---------------|-----------|-----------|----------------|
| **NeurIPS 2025** | May 2025 | 9 + ‚àû refs/app | Double-blind | Encouraged | Optional eval | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê |
| **ICML 2025** | Feb 2025 | 8 + ‚àû refs | Double-blind | Encouraged | Optional | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê |
| **ICLR 2025** | Oct 2024 | No limit (8-10 typical) | Double-blind | Expected | Optional | ‚≠ê‚≠ê‚≠ê‚≠ê |

### Tier 2: Vision & Domain-Specific

| Venue | Deadline | Pages | Anonymization | Code/Data | Artifacts | Best Fit Score |
|-------|----------|-------|---------------|-----------|-----------|----------------|
| **CVPR 2025** | Nov 2024 | 8 + 2 refs | Double-blind | Encouraged | Rebuttal code OK | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê (if vision MIL) |
| **ICCV 2025** | Mar 2025 | 8 + 2 refs | Double-blind | Encouraged | Optional | ‚≠ê‚≠ê‚≠ê‚≠ê (if vision MIL) |
| **ECCV 2025** | Mar 2025 | 14 (LNCS) | Double-blind | Encouraged | Optional | ‚≠ê‚≠ê‚≠ê |
| **MICCAI 2025** | Mar 2025 | 8 (LNCS) | Double-blind | Required | Mandatory for some | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê (if medical) |

### Tier 3: Specialized & Fast-Track

| Venue | Deadline | Pages | Anonymization | Code/Data | Artifacts | Best Fit Score |
|-------|----------|-------|---------------|-----------|-----------|----------------|
| **TMLR** | Rolling | No limit | Single-blind | Required | Required | ‚≠ê‚≠ê‚≠ê‚≠ê |
| **MLSys 2025** | Oct 2024 | 8 + refs | Double-blind | Encouraged | Optional | ‚≠ê‚≠ê (if systems focus) |
| **AISTATS 2025** | Oct 2024 | 8 + ‚àû refs | Double-blind | Encouraged | Optional | ‚≠ê‚≠ê‚≠ê (if theory) |

---

## üìã DETAILED VENUE SPECIFICATIONS

### üèÜ NeurIPS 2025 (RECOMMENDED for broad ML audience)

**Timeline**
- Abstract deadline: ~May 15, 2025
- Paper deadline: ~May 22, 2025
- Reviews released: ~August 2025
- Rebuttal: ~September 2025
- Decisions: ~October 2025
- Conference: December 2025

**Formatting Requirements**
```
Main content:        9 pages (strict)
References:          Unlimited (separate section)
Appendix:            Unlimited (reviewers not required to read)
Template:            neurips_2025.sty (LaTeX required)
Font:                Times, 10pt minimum
Margins:             1 inch all sides
Line numbers:        Required for review
Figures:             Count toward 9-page limit
```

**Anonymization (STRICT)**
- [ ] Remove all author names and affiliations
- [ ] Remove acknowledgments (add after acceptance)
- [ ] Anonymize institution-specific details ("our university" ‚Üí "a large research university")
- [ ] Self-citations allowed but anonymized: "Smith et al. [5] showed..." ‚Üí "[5] showed..."
- [ ] Remove URLs that reveal identity (GitHub with your username)
- [ ] Anonymize dataset names if custom/institutional ("Hospital X dataset" ‚Üí "Dataset A")
- [ ] Check PDF metadata (use `\pdfinfo` to clear author fields)

**Code & Data Requirements**
- **During review**: Optional anonymous repository (GitHub/GitLab anonymous mode, or Dropbox)
- **After acceptance**: Strongly encouraged (90%+ of papers now release code)
- **Format**: Link in supplementary material or "will release upon acceptance" statement
- **Licensing**: Must specify (MIT, Apache 2.0, GPL, etc.)

**Artifact Expectations**
- [ ] **Supplementary material** (100MB limit): 
  - Extended proofs
  - Additional experiments
  - Hyperparameter tables
  - Dataset details
- [ ] **Ethics checklist** (mandatory separate form):
  - Broader impacts
  - Dataset licenses
  - Compute resources
  - Human subjects (if applicable)
  - Dual-use concerns
- [ ] **Reproducibility checklist**:
  - Code availability
  - Data availability
  - Hyperparameters
  - Statistical significance

**MIL Transfer Paper Adaptation**
```
Page budget allocation:
- Introduction: 0.75 pages
- Related work: 1 page
- Problem formulation: 0.5 pages
- Methodology: 1.5 pages
- Experiments: 3.5 pages (multiple source-target pairs)
- Analysis: 1 page (what transfers, what doesn't)
- Limitations: 0.25 pages
- Conclusion: 0.25 pages
- References: Unlimited

Move to appendix:
- Full hyperparameter tables
- Additional domain pairs
- Extended ablations
- Proof of theoretical claims (if any)
- Dataset statistics tables
```

---

### üé® CVPR 2025 (RECOMMENDED if vision-focused MIL)

**Timeline**
- Deadline: ~November 10, 2024
- Reviews: ~February 2025
- Rebuttal: ~March 2025
- Decisions: ~March 2025
- Conference: June 2025

**Formatting Requirements**
```
Main content:        8 pages (strict)
References:          2 additional pages (max 10 total)
Template:            IEEE Conference format
Font:                Times, 10pt
Supplementary:       50MB limit (PDF + ZIP)
```

**Anonymization (VERY STRICT)**
- [ ] Same as NeurIPS, plus:
- [ ] No links to personal websites
- [ ] Blur institutional logos in figures
- [ ] Remove dataset watermarks that reveal institution
- [ ] Check image EXIF data for identifying information

**Code & Data Requirements**
- **During review**: Can provide anonymous link in supplementary
- **Rebuttal**: Can add code to address reviewer concerns
- **After acceptance**: Expected (>85% compliance)
- **Format**: GitHub preferred, with Docker/requirements.txt

**Artifact Expectations**
- [ ] **Supplementary material must include**:
  - Video/animations (if applicable)
  - High-res figures
  - Qualitative results (attention maps, failure cases)
- [ ] **Code expectations**:
  - Training scripts
  - Pretrained checkpoints (if possible)
  - Evaluation scripts
  - Demo notebook

**MIL Transfer Paper Adaptation**
```
Page budget (8 pages tighter than NeurIPS):
- Introduction: 0.6 pages
- Related work: 0.8 pages
- Method: 1.5 pages
- Experiments: 4 pages (focus on 2-3 key domains)
- Analysis: 0.8 pages
- Conclusion: 0.2 pages
- References: 2 pages

Move to supplementary:
- Additional domains (beyond main 2-3)
- Extended related work
- Implementation details
- Full ablation studies
- Negative results

Strategy: Focus main paper on strongest source-target pairs
(e.g., medical‚Üímedical, satellite‚Üísatellite), put cross-domain
transfers (medical‚Üísatellite) in supplementary
```

---

### üè• MICCAI 2025 (RECOMMENDED if medical imaging focus)

**Timeline**
- Deadline: ~March 2025
- Reviews: ~May 2025
- Rebuttal: ~June 2025
- Decisions: ~June 2025
- Conference: October 2025

**Formatting Requirements**
```
Main content:        8 pages (including references!)
Template:            Springer LNCS format
Font:                10pt
Supplementary:       Allowed but discouraged
```

**Anonymization**
- [ ] Standard double-blind
- [ ] **Critical**: Anonymize hospital/clinical site names
- [ ] Remove patient identifiers from figures
- [ ] Anonymize IRB approval numbers

**Code & Data Requirements (STRICTER)**
- **Code**: Expected for acceptance (>95% compliance)
- **Data**: Must describe access protocol if using restricted datasets
- **Clinical data**: Cannot release, must provide:
  - IRB approval letter
  - Data access application process
  - Synthetic data examples (if possible)
- **Reproducibility**: Often required for acceptance

**Artifact Expectations (UNIQUE)**
- [ ] **Docker container** with full pipeline (increasingly common)
- [ ] **Grand Challenge submission** (if applicable to existing challenge)
- [ ] **Clinical validation**: Discussion of clinical utility required
- [ ] **Failure mode analysis**: Medical safety critical

**MIL Transfer Paper Adaptation**
```
Page budget (8 pages INCLUDING references - very tight):
- Introduction: 0.5 pages
- Related work: 0.6 pages (focus on medical MIL)
- Method: 1.2 pages
- Experiments: 4 pages
- Discussion: 0.8 pages
- Conclusion: 0.2 pages
- References: 0.7 pages (cite only essential papers)

Critical additions for MICCAI:
- Clinical motivation (why transfer matters for diagnosis)
- Failure analysis (false negatives/positives)
- Comparison to pathologist performance (if available)
- Discussion of deployment considerations

Focus domains:
- Histopathology (Camelyon, TCGA)
- Radiology (ChestX-ray, brain MRI)
- Avoid non-medical domains in main paper
```

---

### üìä TMLR (RECOMMENDED for thorough empirical work)

**Timeline**
- **Rolling submissions** (submit anytime)
- Review time: 2-4 months
- No rejection, only "accept" or "revise"
- Published immediately upon acceptance

**Formatting Requirements**
```
Main content:        No page limit
Template:            TMLR LaTeX template
Font:                Flexible
Supplementary:       Integrated into main PDF
```

**Anonymization**
- **Single-blind** (reviewers know who you are)
- No need to anonymize self-citations
- Can link to your GitHub directly

**Code & Data Requirements (MANDATORY)**
- [ ] **Code**: Must be provided (public or private repo for reviewers)
- [ ] **Data**: Must describe access or provide
- [ ] **Reproducibility**: Core evaluation criterion
- [ ] **Artifacts**: Checkpoints strongly encouraged

**Artifact Expectations**
- [ ] **Reproducibility package**:
  - Complete training code
  - Evaluation scripts
  - Pretrained models
  - Exact hyperparameters
  - Random seeds
- [ ] **Documentation**:
  - README with setup instructions
  - Expected runtime estimates
  - Hardware requirements

**MIL Transfer Paper Adaptation**
```
No page limit - use it strategically:

Main paper (12-15 pages):
- Introduction: 1 page
- Related work: 2 pages (comprehensive)
- Method: 2 pages
- Experiments: 6 pages (ALL domains, ALL ablations)
- Analysis: 2 pages (deep dive into what transfers)
- Limitations: 0.5 pages
- Conclusion: 0.5 pages
- References: Unlimited

Advantages for MIL transfer:
- Can include ALL source-target pairs tested
- Extensive ablations (instance vs. bag transfer)
- Negative results (when transfer fails)
- Detailed hyperparameter sensitivity
- No need to cut content for space

Timeline advantage:
- Submit when ready (no deadline pressure)
- Revise based on feedback (no rejection)
- Faster publication than conference cycle
```

---

## üó∫Ô∏è VENUE DECISION TREE

```
START: "Do Multiple Instance Learning Models Transfer?"
‚îÇ
‚îú‚îÄ Primary domain?
‚îÇ  ‚îú‚îÄ Medical imaging ‚Üí MICCAI (Oct) or CVPR (Jun)
‚îÇ  ‚îú‚îÄ General vision ‚Üí CVPR (Jun) or ICCV (Sep)
‚îÇ  ‚îú‚îÄ Satellite/remote sensing ‚Üí CVPR or ICLR
‚îÇ  ‚îî‚îÄ Multi-domain/general ‚Üí NeurIPS or ICML
‚îÇ
‚îú‚îÄ Contribution type?
‚îÇ  ‚îú‚îÄ Empirical study (many domains) ‚Üí TMLR or NeurIPS
‚îÇ  ‚îú‚îÄ Theoretical analysis ‚Üí ICML or AISTATS
‚îÇ  ‚îú‚îÄ Systems/efficiency ‚Üí MLSys
‚îÇ  ‚îî‚îÄ Novel architecture ‚Üí ICLR or NeurIPS
‚îÇ
‚îú‚îÄ Timeline constraints?
‚îÇ  ‚îú‚îÄ Need publication in 2025 ‚Üí ICLR (Oct '24) or CVPR (Nov '24)
‚îÇ  ‚îú‚îÄ Flexible ‚Üí TMLR (rolling)
‚îÇ  ‚îî‚îÄ 6+ months available ‚Üí NeurIPS (May '25) or ICML (Feb '25)
‚îÇ
‚îî‚îÄ Reproducibility readiness?
   ‚îú‚îÄ Code/data ready ‚Üí TMLR (required) or NeurIPS (encouraged)
   ‚îú‚îÄ Code in progress ‚Üí CVPR or ICLR (can add during rebuttal)
   ‚îî‚îÄ Restricted data ‚Üí MICCAI (has protocols) or NeurIPS (can describe access)
```

**Recommendation Priority:**
1. **CVPR 2025** (Nov '24) - if vision-focused, strong empirical results
2. **NeurIPS 2025** (May '25) - if multi-domain, broader ML audience
3. **MICCAI 2025** (Mar '25) - if medical-only, clinical impact
4. **TMLR** (rolling) - if comprehensive study, no page limit needed

---

## üìÖ ADAPTED SUBMISSION PLAN (Choose Your Venue)

### PLAN A: CVPR 2025 (Deadline: ~Nov 10, 2024)

**8-Week Sprint Timeline**

```
Week 1-2 (Sep 16-29): Content Finalization
‚ñ° Finalize 2-3 primary source-target pairs for main paper
‚ñ° Complete all experiments for main results
‚ñ° Generate figures (attention maps, transfer curves)
‚ñ° Draft methods and experiments sections

Week 3-4 (Sep 30 - Oct 13): Supplementary & Baselines
‚ñ° Run additional domain pairs for supplementary
‚ñ° Add missing baselines (ImageNet pretrain, domain adaptation)
‚ñ° Create supplementary PDF with extended results
‚ñ° Draft related work and introduction

Week 5 (Oct 14-20): Compliance Sprint
‚ñ° Dataset license audit (especially if using Camelyon, TCGA)
‚ñ° IRB exemption letter (if medical data)
‚ñ° Compute disclosure (GPU hours, CO‚ÇÇ)
‚ñ° Create data statement table

Week 6 (Oct 21-27): Writing & Revision
‚ñ° Complete first full draft
‚ñ° Internal review by co-authors
‚ñ° Address feedback
‚ñ° Proofread

Week 7 (Oct 28 - Nov 3): Formatting & Anonymization
‚ñ° Apply IEEE template
‚ñ° Check 8+2 page limit
‚ñ° Anonymize (remove names, institutions, URLs)
‚ñ° Format references (BibTeX)
‚ñ° Create anonymous GitHub repo

Week 8 (Nov 4-10): Final Submission
‚ñ° Generate camera-ready PDF
‚ñ° Upload supplementary material (code, data, appendix)
‚ñ° Fill out CMT metadata
‚ñ° Submit 24 hours early (Nov 9)
‚ñ° Confirm submission received
```

**Anonymization Checklist (CVPR-specific)**
```latex
% In your LaTeX file:
\documentclass[review]{cvpr}  % 'review' mode for anonymization

% Remove:
\author{Your Name}
\affiliation{Your University}
\thanks{Funding from XYZ}

% Replace with:
\author{Anonymous CVPR Submission \\ Paper ID XXXX}

% Anonymize self-citations:
% Before: "In our previous work [Smith et al. 2023], we showed..."
% After: "Prior work [5] showed..."

% Anonymize datasets:
% Before: "We collected data from Stanford Hospital"
% After: "We used data from a large academic medical center"

% Check figures:
% - Remove institutional logos
% - Blur hospital names in screenshots
% - Remove author names from qualitative examples
```

**Code Release Plan (CVPR)**
```
During review (optional but recommended):
1. Create anonymous GitHub repo:
   - Go to GitHub ‚Üí New Repository
   - Name: "mil-transfer-cvpr2025"
   - Description: "Code for CVPR 2025 submission #XXXX"
   - Make private, add reviewers if requested

2. Include in repo:
   ‚îú‚îÄ‚îÄ README.md (setup instructions)
   ‚îú‚îÄ‚îÄ requirements.txt
   ‚îú‚îÄ‚îÄ train.py (training script)
   ‚îú‚îÄ‚îÄ eval.py (evaluation script)
   ‚îú‚îÄ‚îÄ configs/ (hyperparameters)
   ‚îú‚îÄ‚îÄ models/ (MIL architectures)
   ‚îî‚îÄ‚îÄ data/ (data loading, preprocessing)

3. In paper supplementary:
   "Code available at: https://anonymous.4open.science/r/XXXX"
   OR
   "Code will be released upon acceptance"

After acceptance:
1. De-anonymize repository
2. Add license (MIT recommended)
3. Add citation to paper
4. Upload pretrained checkpoints to Hugging Face or Zenodo
5. Create Colab demo (optional but increases citations)
```

---

### PLAN B: NeurIPS 2025 (Deadline: ~May 22, 2025)

**6-Month Development Timeline**

```
Month 1 (Dec 2024): Experimental Design
‚ñ° Finalize research questions
‚ñ° Select 4-5 source-target domain pairs
‚ñ° Implement baseline methods
‚ñ° Set up experiment tracking (Weights & Biases)

Month 2 (Jan 2025): Core Experiments
‚ñ° Train source models on each domain
‚ñ° Run transfer experiments (frozen, fine-tuned, head-only)
‚ñ° Collect results for primary metrics
‚ñ° Begin ablation studies

Month 3 (Feb 2025): Extended Experiments
‚ñ° Additional baselines (domain adaptation, meta-learning)
‚ñ° Negative transfer analysis
‚ñ° Data efficiency experiments
‚ñ° Cross-architecture transfer

Month 4 (Mar 2025): Analysis & Writing
‚ñ° Feature visualization and analysis
‚ñ° Draft methods, experiments, analysis sections
‚ñ° Create all figures and tables
‚ñ° Internal review

Month 5 (Apr 2025): Compliance & Revision
‚ñ° Dataset license audit
‚ñ° IRB documentation
‚ñ° Compute disclosure
‚ñ° Ethics statement
‚ñ° Limitations section
‚ñ° Address co-author feedback

Month 6 (May 2025): Finalization
Week 1-2: Polish writing, format references
Week 3: Apply NeurIPS template, check 9-page limit
Week 4: Anonymize, prepare supplementary
Week 5: Submit (May 22)
```

**NeurIPS Ethics Checklist (Mandatory)**
```
You must complete a separate checklist covering:

A. Dataset
‚ñ° A1. Dataset licenses documented
‚ñ° A2. Dataset creators cited
‚ñ° A3. IRB approval obtained (if human subjects)
‚ñ° A4. Consent obtained (if new data collection)
‚ñ° A5. PII removed/anonymized
‚ñ° A6. Dataset biases discussed

B. Code
‚ñ° B1. Code will be released (yes/no)
‚ñ° B2. License specified
‚ñ° B3. Dependencies documented
‚ñ° B4. Instructions provided

C. Compute
‚ñ° C1. GPU type and quantity reported
‚ñ° C2. Total compute time reported
‚ñ° C3. CO‚ÇÇ emissions estimated

D. Broader Impacts
‚ñ° D1. Societal impacts discussed
‚ñ° D2. Potential harms identified
‚ñ° D3. Mitigation strategies proposed
‚ñ° D4. Dual-use concerns addressed

E. Theory (if applicable)
‚ñ° E1. Proofs in appendix
‚ñ° E2. Assumptions stated clearly
```

**Page Budget Strategy (NeurIPS 9 pages)**
```
Optimal allocation for MIL transfer paper:

Page 1:
- Title, abstract (0.2)
- Introduction (0.8)

Pages 2-3:
- Related work (1.0)
- Problem formulation (0.5)
- Methodology (0.5)

Pages 4-7:
- Experiments (4 pages):
  * Setup (0.5)
  * Main results: 2-3 domains (1.5)
  * Ablations (1.0)
  * Analysis (1.0)

Pages 8-9:
- Discussion (0.5)
- Limitations (0.3)
- Conclusion (0.2)
- References start (1.0)

Appendix (unlimited):
- Full hyperparameters
- Additional domains
- Extended ablations
- Proofs (if any)
- Dataset details
- Negative results
```

---

### PLAN C: TMLR (Rolling, No Deadline)

**Comprehensive Study Timeline**

```
Phase 1 (Month 1-3): Exhaustive Experiments
‚ñ° Test 6-8 source-target pairs
‚ñ° Multiple MIL architectures (attention, instance, embedding)
‚ñ° All transfer protocols (frozen, fine-tuned, progressive)
‚ñ° Extensive ablations
‚ñ° No need to cut experiments for space

Phase 2 (Month 4): Analysis
‚ñ° Statistical analysis across all conditions
‚ñ° Feature visualization
‚ñ° Failure mode analysis
‚ñ° Theoretical interpretation (if possible)

Phase 3 (Month 5): Writing (No Page Limit)
‚ñ° Comprehensive related work (2-3 pages)
‚ñ° Detailed methodology (2 pages)
‚ñ° Full experimental results (6-8 pages)
‚ñ° In-depth analysis (2-3 pages)
‚ñ° Extensive limitations discussion

Phase 4 (Month 6): Reproducibility Package
‚ñ° Clean, documented code
‚ñ° All training scripts
‚ñ° Pretrained checkpoints for all models
‚ñ° Evaluation scripts
‚ñ° Docker container (optional)
‚ñ° Detailed README

Submit when ready (no deadline pressure)
```

**TMLR Reproducibility Requirements (Mandatory)**
```
Your submission MUST include:

1. Code Repository (public or private for review):
   ‚ñ° Complete training pipeline
   ‚ñ° Evaluation scripts
   ‚ñ° Data preprocessing code
   ‚ñ° Model definitions
   ‚ñ° Configuration files

2. Documentation:
   ‚ñ° README with:
     - Setup instructions
     - Hardware requirements
     - Expected runtime
     - Reproduction steps
   ‚ñ° requirements.txt or environment.yml
   ‚ñ° License file

3. Pretrained Models:
   ‚ñ° Upload to Hugging Face, Zenodo, or Google Drive
   ‚ñ° Include model cards with:
     - Training data
     - Hyperparameters
     - Performance metrics

4. Data Access:
   ‚ñ° If public: provide download links
   ‚ñ° If restricted: describe access process
   ‚ñ° If proprietary: provide synthetic examples

5. Hyperparameters:
   ‚ñ° Complete hyperparameter tables
   ‚ñ° Random seeds used
   ‚ñ° Number of runs for each experiment

Reviewers will attempt to reproduce your results!
```

---

## üéØ VENUE-SPECIFIC ARTIFACT MATRIX

| Artifact Type | NeurIPS | CVPR | MICCAI | TMLR | ICML |
|---------------|---------|------|--------|------|------|
| **Code during review** | Optional | Optional | Optional | Required | Optional |
| **Code after acceptance** | Encouraged (90%) | Expected (85%) | Required (95%) | Required (100%) | Encouraged (80%) |
| **Pretrained models** | Encouraged | Encouraged | Encouraged | Required | Optional |
| **Data access** | Describe | Describe | Describe + IRB | Provide or describe | Describe |
| **Hyperparameters** | Required | Required | Required | Required | Required |
| **Docker container** | Optional | Optional | Encouraged | Optional | Optional |
| **Demo/notebook** | Optional | Encouraged | Optional | Encouraged | Optional |
| **Reproducibility checklist** | Required | Optional | Optional | Required | Optional |
| **Ethics checklist** | Required | Optional | Required | Required | Optional |

---

## üîß ADAPTATION RECOMMENDATIONS

### If Your Paper Currently Has:

**Limited domains (2-3 source-target pairs)**
‚Üí Target: **CVPR** or **ICML** (focused empirical study)
‚Üí Avoid: TMLR (expects comprehensive coverage)

**Many domains (5+ pairs)**
‚Üí Target: **NeurIPS** or **TMLR** (space for full results)
‚Üí Strategy: Main paper shows 3 best, supplementary has rest

**Medical imaging only**
‚Üí Target: **MICCAI** (clinical audience)
‚Üí Add: Clinical validation discussion, failure analysis

**Theoretical contribution**
‚Üí Target: **ICML** or **AISTATS**
‚Üí Add: Proofs in appendix, theoretical analysis section

**Systems/efficiency focus**
‚Üí Target: **MLSys**
‚Üí Add: Latency benchmarks, memory profiling, deployment analysis

**Restricted data (cannot release)**
‚Üí Target: **MICCAI** (has protocols) or **NeurIPS** (can describe)
‚Üí Avoid: TMLR (requires data access)

**Code not ready**
‚Üí Target: **CVPR** or **ICLR** (can add during rebuttal)
‚Üí Avoid: TMLR (requires code upfront)

---

## üì§ NEXT STEPS

**To get a personalized plan, please provide:**

1. **Current paper status**:
   - How many source-target domain pairs tested?
   - Primary domain (medical, satellite, video, general)?
   - Page count of current draft?

2. **Timeline constraints**:
   - When do you need publication (graduation, job market)?
   - Nearest acceptable deadline?

3. **Artifact readiness**:
   - Is code ready to release?
   - Can you release data, or is it restricted?
   - Do you have pretrained checkpoints?

4. **Compliance status**:
   - Using medical data (need IRB)?
   - Compute resources documented?
   - Ethics statement drafted?

**Upload your current draft** and I'll:
- ‚úÖ Check compliance with specific venue requirements
- üìè Assess if content fits page limits
- üîß Identify what to move to appendix/supplementary
- ‚ö†Ô∏è Flag anonymization risks
- üìã Generate venue-specific checklist with ‚úì/‚úó
- üóìÔ∏è Create personalized timeline to nearest deadline

**Which venue are you leaning toward?** I can provide a detailed submission package for that specific conference.